Battle Cynthia L, Weinstock Lauren M, Howard Margaret
Alpert Medical School of Brown University, Department of Psychiatry & Human Behavior, USA; Butler Hospital, Psychosocial Research Program, USA; Women & Infants' Hospital of Rhode Island, Department of Medicine, USA.
Alpert Medical School of Brown University, Department of Psychiatry & Human Behavior, USA; Butler Hospital, Psychosocial Research Program, USA.
J Affect Disord. 2014 Apr;158:97-100. doi: 10.1016/j.jad.2014.02.002. Epub 2014 Feb 11.
Pregnancy and the postpartum period can be destabilizing for women with bipolar disorder (BD), and treatment decisions particularly complex. Yet, to date, relatively little research has focused on perinatal BD.
Following IRB approval, trained raters reviewed clinical records of 334 women who had sought treatment at a specialized partial hospitalization program serving perinatal women, including demographic, clinical, and treatment history information as noted in each patient׳s chart by treating providers.
Slightly over 10% of the perinatal sample was diagnosed with Bipolar I, Bipolar II, or Bipolar NOS Disorder. In addition, 26% of the sample, regardless of diagnostic status, reported recent, abnormally elevated mood persisting 4 or more days. Compared to women with other Axis I disorders, women with a BD diagnosis were more likely to report a substance abuse history, prior suicide attempts, and more extensive psychiatric histories, including greater use of pharmacotherapy. Pregnant women with BD were more likely to take psychotropic medications prenatally, and postpartum women with BD reported higher rates of birth complications and difficulty breastfeeding.
This research is limited by use of retrospective data, and utilization of self-report and clinician diagnosis, rather than structured interviews.
Even in the context of a partial hospital sample with high levels of symptoms and impairment, the clinical features of perinatal women with BD stand out as markedly more severe in comparison to those of women seeking care for other perinatal psychiatric conditions. Risk for suicide, substance abuse, and difficulties in the mother-child relationship are concerns.
妊娠和产后时期对于双相情感障碍(BD)女性而言可能会导致病情不稳定,治疗决策尤其复杂。然而,迄今为止,相对较少的研究聚焦于围产期双相情感障碍。
经机构审查委员会(IRB)批准后,训练有素的评估人员查阅了334名在专门为围产期女性服务的部分住院项目中寻求治疗的女性的临床记录,包括治疗提供者在每位患者病历中记录的人口统计学、临床和治疗史信息。
略超过10%的围产期样本被诊断为双相I型、双相II型或未特定型双相情感障碍。此外,26%的样本,无论诊断状况如何,均报告近期存在持续4天或更长时间的异常情绪高涨。与患有其他轴I障碍的女性相比,被诊断为双相情感障碍的女性更有可能报告有药物滥用史、既往自杀未遂史以及更广泛的精神病史,包括更多地使用药物治疗。患有双相情感障碍的孕妇在产前更有可能服用精神药物,而患有双相情感障碍的产后女性报告的分娩并发症发生率和母乳喂养困难率更高。
本研究受回顾性数据的使用以及自我报告和临床医生诊断而非结构化访谈的限制。
即使在症状和损害程度较高的部分住院样本中,与因其他围产期精神疾病寻求治疗的女性相比,围产期双相情感障碍女性的临床特征仍明显更为严重。自杀风险、药物滥用以及母婴关系方面的困难令人担忧。